Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05781061
Other study ID # 1059
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 16, 2023
Est. completion date June 15, 2023

Study information

Verified date March 2023
Source Gynuity Health Projects
Contact Elizabeth Raymond, MD
Phone (212) 448-1230
Email eraymond@gynuity.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators propose to conduct a parallel study to MA-ASAP (ClinicalTrials.gov Identifier: NCT05278780) at an independent clinic.


Description:

In this study, the investigators propose to conduct a parallel study to the MA-ASAP pilot study (ClinicalTrials.gov Identifier: NCT05278780) at one or more independent abortion clinics. This new study will be similar in structure to pilot study, except that all completed screening questionnaires will be sent to the study site rather than only those deemed eligible according a computer algorithm. The investigators expect that this change will better serve the needs of both clinics and patients, and it will also allow us to assess whether the algorithm is overly restrictive, i.e., whether it is excluding patients who are in fact eligible for MA. The primary goal of the study is to collect data on feasibility of the approach and safety. Secondarily, the investigators aim to assess the ability of a defined set of responses to the screening questionnaire to predict the clinician's decision about whether a clinical consultation is needed.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date June 15, 2023
Est. primary completion date June 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Can speak and read English - Has an address in a state where the study clinicians are licensed to practice medicine and where the service is legal - Is old enough to consent to abortion and study participation without parental consent in the study state - Has reviewed the study website - Has had a positive pregnancy test - Has signed the study informed consent form (ICF), which will be included within the questionnaire - Is pregnant with a gestational age of =77 days from last menstrual period - Desires MA - Has no symptoms of or risk factors for ectopic pregnancy - Has no medical contraindications to MA, specifically: Hemorrhagic disorder or concurrent anticoagulant therapy Chronic adrenal failure Concurrent long-term systemic corticosteroid therapy Inherited porphyria Allergy to mifepristone or misoprostol, or other prostaglandin - Is not asked by the site to have a synchronous consultation with clinician OR facility-based tests such as ultrasound, laboratory tests, examination, etc. - Is comfortable obtaining the abortion pills without a pre-treatment ultrasound and without speaking by phone or video with the abortion provider.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Screening for Eligibility
Asynchronous Screening for MA Eligibility

Locations

Country Name City State
United States All Families Healthcare Whitefish Montana

Sponsors (2)

Lead Sponsor Collaborator
Gynuity Health Projects All Families Healthcare

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of participant questions The proportion of participants who have questions after completing the questionnaire and the types of questions that are asked. 6 months
Primary Proportion of participants that are followed through the study The numbers and proportions of people who complete the questionnaire once initiated, are reached by study staff after submitting a completed questionnaire, and are ultimately followed through the study. 6 months
Primary Incidence of reported problems by site staff Problems with the study process as reported by site staff 6 months
Primary Study site satisfaction (self-reported) Interest on the part of study sites to continue to utilize this approach to MA provision after the study ends. 6 months
Primary Incidence of Treatment-Emergent Adverse Events Proportion of treated participants with SAE related to the study 6 months
Secondary Efficacy of computer algorithm to determine MA eligibility We will estimate the predictive value of this algorithm for selecting participants who were deemed eligible for MA or ultimately did receive treatment without a synchronous consultation or facility-based tests 6 months
See also
  Status Clinical Trial Phase
Completed NCT03989869 - Very Early Medical Abortion N/A
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Recruiting NCT05182008 - A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial N/A
Completed NCT04432792 - The California Home Abortion by Telehealth (CHAT) Study
Completed NCT03417362 - Delivery of Audiovisual Information on Early Medical Abortion N/A
Completed NCT04824118 - Clotting Parameters After Medical Abortion
Recruiting NCT04458558 - Improving Access to Abortion in the Republic of Georgia Phase 4
Active, not recruiting NCT05278780 - Medication Abortion With Autonomous Self-Assessment Project N/A
Completed NCT03320057 - Medication Abortion Via Pharmacy Dispensing Phase 4
Not yet recruiting NCT05986357 - The Relation of High Sensitivity C Reactive Protein and Total Leucocytic Count Levels in Threatened Abortion
Completed NCT03047551 - Transabdominal and Transvaginal Sonography in Medical Abortion N/A
Completed NCT03913104 - Mail Order Mifepristone Study Phase 4
Terminated NCT04139382 - Using Telemedicine to Improve Early Medical Abortion at Home N/A
Recruiting NCT05147857 - Mid Trimester Abortion Effectiveness by Dilapan s N/A
Completed NCT02522078 - Dry vs Wet Misoprostol for Cervical Dilation in First Trimester Abortion Phase 4
Completed NCT05635955 - Remimazolam Versus Propofol for Painless Abortion Phase 2
Active, not recruiting NCT05342974 - Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy Early Phase 1
Completed NCT03900728 - Auriculotherapy During Medication Abortion N/A